These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
509 related articles for article (PubMed ID: 23968914)
1. Synergistic inhibition of cell migration by tetraspanin CD82 and gangliosides occurs via the EGFR or cMet-activated Pl3K/Akt signalling pathway. Li Y; Huang X; Zhang J; Li Y; Ma K Int J Biochem Cell Biol; 2013 Nov; 45(11):2349-58. PubMed ID: 23968914 [TBL] [Abstract][Full Text] [Related]
2. Ganglioside GM3 promotes HGF-stimulated motility of murine hepatoma cell through enhanced phosphorylation of cMet at specific tyrosine sites and PI3K/Akt-mediated migration signaling. Li Y; Huang X; Zhong W; Zhang J; Ma K Mol Cell Biochem; 2013 Oct; 382(1-2):83-92. PubMed ID: 23749170 [TBL] [Abstract][Full Text] [Related]
3. Gangliosides and CD82 inhibit the motility of colon cancer by downregulating the phosphorylation of EGFR at different tyrosine sites and signaling pathways. Huang X; Li Y; He X; Chen Y; Wei W; Yang X; Ma K Mol Med Rep; 2020 Nov; 22(5):3994-4002. PubMed ID: 33000220 [TBL] [Abstract][Full Text] [Related]
4. Ganglioside GM3 exerts opposite effects on motility via epidermal growth factor receptor and hepatocyte growth factor receptor-mediated migration signaling. Li Y; Huang X; Wang C; Li Y; Luan M; Ma K Mol Med Rep; 2015 Apr; 11(4):2959-66. PubMed ID: 25503644 [TBL] [Abstract][Full Text] [Related]
5. Ganglioside GM2/GM3 complex affixed on silica nanospheres strongly inhibits cell motility through CD82/cMet-mediated pathway. Todeschini AR; Dos Santos JN; Handa K; Hakomori SI Proc Natl Acad Sci U S A; 2008 Feb; 105(6):1925-30. PubMed ID: 18272501 [TBL] [Abstract][Full Text] [Related]
6. Ganglioside GM3 inhibits hepatoma cell motility via down-regulating activity of EGFR and PI3K/AKT signaling pathway. Huang X; Li Y; Zhang J; Xu Y; Tian Y; Ma K J Cell Biochem; 2013 Jul; 114(7):1616-24. PubMed ID: 23355442 [TBL] [Abstract][Full Text] [Related]
7. Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells. Park SY; Yoon SJ; Freire-de-Lima L; Kim JH; Hakomori SI Carbohydr Res; 2009 Aug; 344(12):1479-86. PubMed ID: 19559406 [TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor and hepatocyte growth factor cooperate to enhance cell proliferation, scatter, and invasion in murine mammary epithelial cells. Accornero P; Miretti S; Starvaggi Cucuzza L; Martignani E; Baratta M J Mol Endocrinol; 2010 Feb; 44(2):115-25. PubMed ID: 19850646 [TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of cMet tyrosine residues in murine ascitic hepatic cancer cell lines with different lymph node metastatic potentials. Li Y; Huang X; Zhang Q; Ma K Mol Med Rep; 2013 Aug; 8(2):655-61. PubMed ID: 23778885 [TBL] [Abstract][Full Text] [Related]
10. Cross talk between c-Met and epidermal growth factor receptor during retinal pigment epithelial wound healing. Xu KP; Yu FS Invest Ophthalmol Vis Sci; 2007 May; 48(5):2242-8. PubMed ID: 17460286 [TBL] [Abstract][Full Text] [Related]
11. Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms. Matte I; Lane D; Laplante C; Garde-Granger P; Rancourt C; Piché A Int J Cancer; 2015 Jul; 137(2):289-98. PubMed ID: 25482018 [TBL] [Abstract][Full Text] [Related]
12. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells. Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913 [TBL] [Abstract][Full Text] [Related]
14. Suppression of epidermal growth factor receptor signaling by protein kinase C-alpha activation requires CD82, caveolin-1, and ganglioside. Wang XQ; Yan Q; Sun P; Liu JW; Go L; McDaniel SM; Paller AS Cancer Res; 2007 Oct; 67(20):9986-95. PubMed ID: 17942932 [TBL] [Abstract][Full Text] [Related]
15. Ganglioside GM2-tetraspanin CD82 complex inhibits met and its cross-talk with integrins, providing a basis for control of cell motility through glycosynapse. Todeschini AR; Dos Santos JN; Handa K; Hakomori SI J Biol Chem; 2007 Mar; 282(11):8123-33. PubMed ID: 17215249 [TBL] [Abstract][Full Text] [Related]
16. Effects of gangliosides on the differentiation of human mesenchymal stem cells into osteoblasts by modulating epidermal growth factor receptors. Kim SM; Jung JU; Ryu JS; Jin JW; Yang HJ; Ko K; You HK; Jung KY; Choo YK Biochem Biophys Res Commun; 2008 Jul; 371(4):866-71. PubMed ID: 18471991 [TBL] [Abstract][Full Text] [Related]
17. Migration induced by epidermal and hepatocyte growth factors in oral squamous carcinoma cells in vitro: role of MEK/ERK, p38 and PI-3 kinase/Akt. Brusevold IJ; Aasrum M; Bryne M; Christoffersen T J Oral Pathol Med; 2012 Aug; 41(7):547-58. PubMed ID: 22413835 [TBL] [Abstract][Full Text] [Related]
18. The involvement of the docking protein Gab1 in mitogenic signalling induced by EGF and HGF in rat hepatocytes. Aasrum M; Ødegård J; Sandnes D; Christoffersen T Biochim Biophys Acta; 2013 Dec; 1833(12):3286-3294. PubMed ID: 24126105 [TBL] [Abstract][Full Text] [Related]
19. Regulation of c-Met signaling by the tetraspanin KAI-1/CD82 affects cancer cell migration. Takahashi M; Sugiura T; Abe M; Ishii K; Shirasuna K Int J Cancer; 2007 Nov; 121(9):1919-1929. PubMed ID: 17621632 [TBL] [Abstract][Full Text] [Related]
20. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways. Tuck AB; Hota C; Wilson SM; Chambers AF Oncogene; 2003 Feb; 22(8):1198-205. PubMed ID: 12606946 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]